Neurobiology of Aging
Volume 29, Issue 7 , Pages 981-991 , July 2008

Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers

  • Paul R. Borghesani

      Affiliations

    • Mental Illness Research, Education, and Clinical Center (MIRECC), Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA
    • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA
    • Corresponding Author InformationCorresponding author at: Veterans Affairs Puget Sound Health Care System (VAPSHCS), S-116 6East, 1660 Columbian Way, Seattle, WA 98108, USA. Tel.: +1 206 277 1337; fax: +1 206 277 4856.
    • ,
  • L. Clark Johnson

      Affiliations

    • Department of Psychosocial and Community Health Nursing, University of Washington School of Nursing, Seattle, WA 98195, USA
    • ,
  • Amy L. Shelton

      Affiliations

    • Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD 21218, USA
    • ,
  • Elaine R. Peskind

      Affiliations

    • Mental Illness Research, Education, and Clinical Center (MIRECC), Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA
    • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA
    • Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA
    • ,
  • Elizabeth H. Aylward

      Affiliations

    • Department of Radiology, University of Washington School of Medicine, Seattle, WA 98195, USA
    • ,
  • Gerard D. Schellenberg

      Affiliations

    • Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA
    • ,
  • Monique M. Cherrier

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA
    • Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA

Received 21 August 2006 ,Revised 5 January 2007 ,Accepted 21 January 2007.

References 

  1. Bassett SS, Yousem DM, Cristinzio C, Kusevic I, Yassa MA, Caffo BS, et al. Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain. 2006;129(Pt. 5):1229–1239
  2. Bondi MW, Houston WS, Eyler LT, Brown GG. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology. 2005;64(3):501–508
  3. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 2000;343(7):450–456
  4. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol. Aging. 1997;18(4 Suppl.):S85–S88
  5. Burgess N, Becker S, King JA, O’Keefe J. Memory for events and their spatial context: models and experiments. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2001;356(1413):1493–1503
  6. Burgess N, Maguire EA, O’Keefe J. The human hippocampus and spatial and episodic memory. Neuron. 2002;35(4):625–641
  7. Burggren AC, Small GW, Sabb FW, Bookheimer SY. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am. J. Geriatr. Psychiatry. 2002;10(1):44–51
  8. Chen J, Myerson J, Hale S. Age-related dedifferentiation of visuospatial abilities. Neuropsychologia. 2002;40(12):2050–2056
  9. Cohen RM, Small C, Lalonde F, Friz J, Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology. 2001;57(12):2223–2228
  10. Coleman RE. Positron emission tomography diagnosis of Alzheimer's disease. Neuroimaging Clin. N. Am. 2005;15(4):837–846x
  11. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921–923
  12. Craft S, Zallen G, Baker LD. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 1992;14(2):253–267
  13. D’Esposito M, Deouell LY, Gazzaley A. Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging. Nat. Rev. Neurosci. 2003;4(11):863–872
  14. de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose/poitron-emission tomography (FDG/PET). Proc. Natl. Acad. Sci. U.S.A. 2001;98(19):10966–10971
  15. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65(3):404–411
  16. Donaldson DI, Buckner RL. Effective Paradigm Design. Oxford University Press; 2001;
  17. Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, et al. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology. 2005;64(1):102–107
  18. Ekstrom AD, Kahana MJ, Caplan JB, Fields TA, Isham EA, Newman EL, et al. Cellular networks underlying human spatial navigation. Nature. 2003;425(6954):184–188
  19. Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, et al. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch. Neurol. 2005;62(12):1881–1888
  20. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12(3):189–198
  21. Galasko D. Biomarkers for Alzheimer's disease—clinical needs and application. J. Alzheimers Dis. 2005;8(4):339–346
  22. Grady CL, Maisog JM, Horwitz B, Ungerleider LG, Mentis MJ, Salerno JA, et al. Age-related changes in cortical blood flow activation during visual processing of faces and location. J. Neurosci. 1994;14(3 Pt. 2):1450–1462
  23. Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J. Neurosci. 2003;23(3):986–993
  24. Greenwood PM, Lambert C, Sunderland T, Parasuraman R. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results from the National Institute of Mental Health's BIOCARD study. Neuropsychology. 2005;19(2):199–211
  25. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. U.S.A. 2004;101(13):4637–4642
  26. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, et al. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol. Aging. 2007;28(2):238–247
  27. Hartley T, Maguire EA, Spiers HJ, Burgess N. The well-worn route and the path less traveled: distinct neural bases of route following and wayfinding in humans. Neuron. 2003;37(5):877–888
  28. Henson R. A mini-review of fMRI studies of human medial temporal lobe activity associated with recognition memory. Q. J. Exp. Psychol. B. 2005;58(3–4):340–360
  29. Higuchi M, Arai H, Nakagawa T, Higuchi S, Muramatsu T, Matsushita S, et al. Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease. Neuroreport. 1997;8(12):2639–2643
  30. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 1990;31(3):545–548
  31. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825–841
  32. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001;5(2):143–156
  33. Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, et al. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J. Neurosci. 2006;26(22):6069–6076
  34. Knopman DS, Boeve BF, Petersen RC. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin. Proc. 2003;78(10):1290–1308
  35. Lehtovirta M, Soininen H, Laakso MP, Partanen K, Helisalmi S, Mannermaa A, et al. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. J. Neurol. Neurosurg. Psychiatry. 1996;60(6):644–649
  36. Lind J, Persson J, Ingvar M, Larsson A, Cruts M, Van Broeckhoven C, et al. Reduced functional brain activity response in cognitively intact apolipoprotein E {varepsilon}4 carriers. Brain. 2006;129(Pt 5):1240–1248
  37. Lustig C, Snyder AZ, Bhakta M, O’Brien KC, McAvoy M, Raichle ME, et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc. Natl. Acad. Sci. U.S.A. 2003;100(24):14504–14509
  38. Mattis S. Dementia Rating Scale: Professional Manual. Odessa, FL: Psychological Assessments Resources; 2004;
  39. Mielke R, Zerres K, Uhlhaas S, Kessler J, Heiss WD. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease. Neurosci. Lett. 1998;254(1):49–52
  40. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging. 2005;32(4):486–510
  41. Mosconi L, De Santi S, Rusinek H, Convit A, de Leon MJ. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease. Expert Rev. Neurother. 2004;4(5):831–849
  42. O’Keefe J, Nadel L. The Hippocampus as a Cognitive Map. Oxford: Claredon Press; 1978;
  43. Park DC, Polk TA, Park R, Minear M, Savage A, Smith MR. Aging reduces neural specialization in ventral visual cortex. Proc. Natl. Acad. Sci. U.S.A. 2004;101(35):13091–13095
  44. Petrella JR, Lustig C, Bucher LA, Jha AP, Doraiswamy PM. Prefrontal activation patterns in subjects at risk for Alzheimer disease. Am. J. Geriatr. Psychiatry. 2002;10(1):112–113
  45. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann. Neurol. 1999;45(3):358–368
  46. Rajah MN, D’Esposito M. Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory. Brain. 2005;128(Pt. 9):1964–1983
  47. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U.S.A. 2004;101(1):284–289
  48. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl. Acad. Sci. U.S.A. 2005;102(23):8299–8302
  49. Rugg MD, Otten LJ, Henson RN. The neural basis of episodic memory: evidence from functional neuroimaging. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2002;357(1424):1097–1110
  50. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43(8):1467–1472
  51. Scarmeas N, Anderson KE, Hilton J, Park A, Habeck C, Flynn J, et al. APOE-dependent PET patterns of brain activation in Alzheimer disease. Neurology. 2004;63(5):913–915
  52. Scarmeas N, Habeck C, Anderson KE, Hilton J, Devanand DP, Pelton GH, et al. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele). Am. J. Geriatr. Psychiatry. 2004;12(6):596–605
  53. Scarmeas N, Habeck CG, Hilton J, Anderson KE, Flynn J, Park A, et al. APOE related alterations in cerebral activation even at college age. J. Neurol. Neurosurg. Psychiatry. 2005;76(10):1440–1444
  54. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993;90(20):9649–9653
  55. Shelton AL, Gabrieli JD. Neural correlates of encoding space from route and survey perspectives. J. Neurosci. 2002;22(7):2711–2717
  56. Shelton AL, McNamara TP. Orientation and perspective dependence in route and survey learning. J. Exp. Psychol. Learn. Mem. Cogn. 2004;30(1):158–170
  57. Shelton, A.L., Pippett, H.A., 2006. Fixed versus dynamic orientations in environmental learning from ground-level and aerial perspectives. Psychol. Res. Sept 7, [Epub ahead of print].
  58. Small BJ, Herlitz A, Fratiglioni L, Almkvist O, Backman L. Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology. 1997;11(3):413–420
  59. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, et al Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA. 1995;273(12):942–947
  60. Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA. 1997;278(16):1363–1371
  61. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology. 1999;53(7):1391–1396
  62. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Women at risk for AD show increased parietal activation during a fluency task. Neurology. 2002;58(8):1197–1202
  63. Smith CD, Kryscio RJ, Schmitt FA, Lovell MA, Blonder LX, Rayens WS, et al. Longitudinal functional alterations in asymptomatic women at risk for Alzheimer's disease. J. Neuroimaging. 2005;15(3):271–277
  64. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23(Suppl. 1):S208–S219
  65. Starr JM, Loeffler B, Abousleiman Y, Simonotto E, Marshall I, Goddard N, et al. Episodic and semantic memory tasks activate different brain regions in Alzheimer disease. Neurology. 2005;65(2):266–269
  66. Tanzi RE, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 2001;32(2):181–184
  67. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 2004;62(11):1977–1983
  68. Vogeley K, May M, Ritzl A, Falkai P, Zilles K, Fink GR. Neural correlates of first-person perspective as one constituent of human self-consciousness. J. Cogn. Neurosci. 2004;16(5):817–827
  69. Wagner AD, Shannon BJ, Kahn I, Buckner RL. Parietal lobe contributions to episodic memory retrieval. Trends Cogn. Sci. 2005;9(9):445–453
  70. Walker LC, Ibegbu CC, Todd CW, Robinson HL, Jucker M, LeVine H, et al. Emerging prospects for the disease-modifying treatment of Alzheimer's disease. Biochem. Pharmacol. 2005;69(7):1001–1008
  71. Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, et al. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am. J. Psychiatry. 2006;163(9):1603–1610
  72. Woolrich MW, Behrens TE, Beckmann CF, Jenkinson M, Smith SM. Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage. 2004;21(4):1732–1747

PII: S0197-4580(07)00019-X

doi: 10.1016/j.neurobiolaging.2007.01.012

Neurobiology of Aging
Volume 29, Issue 7 , Pages 981-991 , July 2008

Article Tools

* Image Usage & Resolution